Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Queensland Health
Covington
Chubb
Julphar
Harvard Business School
Fuji
Cerilliant

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TEDIZOLID PHOSPHATE

« Back to Dashboard

Clinical Trials for Tedizolid Phosphate

Trial ID Title Status Sponsor Phase Summary
NCT01170221 TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. Completed Trius Therapeutics LLC Phase 3 This is a randomized, double-blind, double dummy, multicenter Phase 3 study of oral TR-701 FA 200 mg once daily for 6 days versus oral Zyvox® (linezolid) 600 mg every 12 hours for 10 days for the treatment of ABSSSI in adults. Approximately 75 to 100 sites globally will participate in this study. Patients with an ABSSSI caused by suspected or documented gram positive pathogen(s) at baseline will be randomized 1:1 to study treatment
NCT01539473 A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge Completed Trius Therapeutics LLC Phase 1 Phase 1 study to determine the effect of oral TR-701 FA on SBP response when administered with tyramine
NCT01577459 A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response Completed Trius Therapeutics LLC Phase 1 This is a randomized, double-blinded, placebo-controlled, crossover study to evaluate the pressor effects of pseudoephedrine when administered with TR-701 FA in healthy adult volunteers.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Tedizolid Phosphate

Condition Name

Condition Name for Tedizolid Phosphate
Intervention Trials
Skin Diseases, Bacterial 2
Healthy Subjects 2
Gram-Positive Bacterial Infections 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Tedizolid Phosphate
Intervention Trials
Infection 7
Communicable Diseases 5
Bacterial Infections 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Tedizolid Phosphate

Trials by Country

Trials by Country for Tedizolid Phosphate
Location Trials
United States 36
China 17
Brazil 3
Canada 3
Argentina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Tedizolid Phosphate
Location Trials
California 6
Texas 3
Louisiana 2
Ohio 2
New Jersey 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Tedizolid Phosphate

Clinical Trial Phase

Clinical Trial Phase for Tedizolid Phosphate
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Tedizolid Phosphate
Clinical Trial Phase Trials
Completed 7
Recruiting 3
Not yet recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Tedizolid Phosphate

Sponsor Name

Sponsor Name for Tedizolid Phosphate
Sponsor Trials
Merck Sharp & Dohme Corp. 5
Trius Therapeutics LLC 4
Cubist Pharmaceuticals LLC 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Tedizolid Phosphate
Sponsor Trials
Industry 11
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
US Army
McKesson
Teva
UBS
Mallinckrodt
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.